Table 1

Liver weight, ACO, and CYP4A in CD-1 mice

Liver Weight ± S.E.M.ACO ± S.E.M.CYP4A ± S.E.M.
MaleFemaleMaleFemaleMaleFemale
% body weight (% change) nmol/min/mg (% change) AU (% change)
Vehicle6.19  ± 0.165.22  ± 0.143.16  ± 0.213.69  ± 0.290.33  ± 0.040.26  ± 0.04
TZD, 500 mg/kg/day7.25  ± 0.26 (17)1-160 6.65  ± 0.11 (27)1-160 11.38  ± 2.98 (260)1-150 12.73  ± 2.86 (245)1-150 0.73  ± 0.05 (125)1-160 0.84  ± 0.05 (221)1-160
Vehicle5.63  ± 0.115.20  ± 0.133.48  ± 0.424.63  ± 0.670.31  ± 0.050.19  ± 0.02
L-783,483, 500 mg/kg/day7.65  ± 0.23 (36)1-160 8.27  ± 0.23 (59)1-160 24.63  ± 3.21 (720)1-160 25.95  ± 3.37 (460)1-150 0.94  ± 0.06 (206)1-160 1.06  ± 0.13 (466)1-150

Four CD-1 mice (each sex) were treated for 4 days as indicated; data for TZD represent two independent studies (eight animals per sex total). Values in parentheses represent percentage increase over concurrent vehicle control. CYP4A values have had an average preimmune background of 0.16 AU subtracted (previously determined).

    • 1-150P ≤ .05;

    • 1-160P ≤ .01. P values were calculated using the appropriate t test (equal or unequal variance) based on F test results.